摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-(三氟甲基)-3,4-二氢-1H-喹喔啉-2-酮 | 716-81-4

中文名称
7-(三氟甲基)-3,4-二氢-1H-喹喔啉-2-酮
中文别名
——
英文名称
7-(trifluoromethyl)-3,4-dihydroquinoxalin-2(1H)-one
英文别名
7-(trifluoromethyl)-3,4-dihydro-1H-quinoxalin-2-one
7-(三氟甲基)-3,4-二氢-1H-喹喔啉-2-酮化学式
CAS
716-81-4
化学式
C9H7F3N2O
mdl
MFCD01435942
分子量
216.163
InChiKey
DYBIQELZTJXUKA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    150-152 °C
  • 沸点:
    337.7±42.0 °C(Predicted)
  • 密度:
    1.365±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    15
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.222
  • 拓扑面积:
    41.1
  • 氢给体数:
    2
  • 氢受体数:
    5

安全信息

  • 海关编码:
    2933990090

SDS

SDS:bad716e5cd69375e29cbe5b9f4bbd7c6
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 7-(Trifluoromethyl)-3,4-dihydro-1H-quinoxalin-2-one
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 7-(Trifluoromethyl)-3,4-dihydro-1H-quinoxalin-2-one
CAS number: 716-81-4

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C9H7F3N2O
Molecular weight: 216.2

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen fluoride.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    固相无痕合成喹喔啉类
    摘要:
    报道了在三个组合步骤中的固相无痕合成喹喔啉酮。用氨基酸甲酯将醛官能化的聚苯乙烯树脂还原烷基化,然后使与树脂结合的仲胺与邻氟硝基苯反应。生成的邻硝基苯胺被氯化锡还原成二苯胺,并自发环化。所获得的二氢喹喔啉酮的酰胺氮被烷基卤化物烷基化。从树脂上裂解后,将二氢喹喔啉酮空气氧化为喹喔啉酮。
    DOI:
    10.1016/s0040-4039(00)00297-5
  • 作为产物:
    描述:
    4-氟-3-硝基三氟甲苯 在 palladium 10% on activated carbon 、 氢气potassium carbonate 作用下, 以 乙醇N,N-二甲基甲酰胺 为溶剂, 反应 4.0h, 生成 7-(三氟甲基)-3,4-二氢-1H-喹喔啉-2-酮
    参考文献:
    名称:
    可见光有机光氧化还原催化和不对称有机催化的组合用于二氢喹喔啉酮与酮的对映选择性曼尼希反应
    摘要:
    描述了通过有机光氧化还原和不对称有机催化的结合,二氢喹喔啉酮与酮的对映选择性光氧化曼尼希反应。该方案具有非常温和的反应条件,使用简单且廉价的催化剂(曙红Y和(S)-脯氨酸)合成手性喹喔啉衍生物,具有良好至高产率(高达94%)和出色的对映选择性(高达99%ee) 。
    DOI:
    10.1021/acs.orglett.9b02157
点击查看最新优质反应信息

文献信息

  • [EN] NON-PEPTIDIC HETEROCYCLE-CONTAINING COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE<br/>[FR] COMPOSÉS NON PÉPTIDIQUES CONTENANT DES HÉTÉROCYCLES POUR LE TRAITEMENT DE LA MALADIE D'ALZHEIMER
    申请人:UNIV ALBERTA
    公开号:WO2020215157A1
    公开(公告)日:2020-10-29
    The present disclosure provides non-peptidic heterocycle-containing amylin receptor antagonist compounds, compositions that include the subject compounds, methods for preparing and using the amylin receptor antagonists, and compositions containing the amylin receptor antagonists for treating, preventing, or ameliorating Alzheimer's disease. Aspects of the present disclosure include a method of inhibiting activity of an amylin receptor by administering to a subject in need thereof a therapeutically effective amount of an amylin receptor antagonist.
    本公开提供了含非肽杂环的胰岛素类受体拮抗剂化合物,包括该类化合物的组合物,用于制备和使用胰岛素类受体拮抗剂的方法,以及含有胰岛素类受体拮抗剂的组合物,用于治疗、预防或改善阿尔茨海默病。本公开的方面包括通过向需要的受试者投与治疗有效量的胰岛素类受体拮抗剂来抑制胰岛素类受体活性的方法。
  • Quinoxaline compounds as hypnotic agents
    申请人:Eli Lilly and Company
    公开号:US03962440A1
    公开(公告)日:1976-06-08
    The present invention is concerned with the use of certain quinoxaline compounds as hypnotic agents.
    本发明涉及使用某些喹诺啉化合物作为催眠药剂。
  • A solid phase traceless synthesis of quinoxalinones
    作者:Viktor Krchňák、Lajos Szabo、Josef Vágner
    DOI:10.1016/s0040-4039(00)00297-5
    日期:2000.4
    A solid-phase traceless synthesis of quinoxalinones in three combinatorial steps is reported. An aldehyde functionalized polystyrene resin was reductively alkylated by amino acid methyl esters, and then the resin bound secondary amines were reacted with o-fluoronitrobenzenes. The resulting o-nitroanilines were reduced by tin chloride to the dianilines, which spontaneously cyclized. The amide nitrogen
    报道了在三个组合步骤中的固相无痕合成喹喔啉酮。用氨基酸甲酯将醛官能化的聚苯乙烯树脂还原烷基化,然后使与树脂结合的仲胺与邻氟硝基苯反应。生成的邻硝基苯胺被氯化锡还原成二苯胺,并自发环化。所获得的二氢喹喔啉酮的酰胺氮被烷基卤化物烷基化。从树脂上裂解后,将二氢喹喔啉酮空气氧化为喹喔啉酮。
  • Methods of using thiazolobenzoheterocycles
    申请人:Rhone-Poulenc Rorer S.A.
    公开号:US20030055031A1
    公开(公告)日:2003-03-20
    Methods of using compounds of formula (I): 1 their racemates, enantiomers, diastereoisomers and inorganic acid salts and organic acid salts thereof.
    使用式(I)化合物的方法:1.使用它们的外消旋体、对映体、非对映异构体和无机酸盐以及有机酸盐。
  • [EN] HETEROCYCLIC COMPOUND, APPLICATION THEREOF, AND COMPOSITION CONTAINING SAME<br/>[FR] COMPOSÉ HÉTÉROCYCLIQUE, SON APPLICATION ET COMPOSITION LE CONTENANT<br/>[ZH] 一种含杂环的化合物、其应用及含其的组合物
    申请人:GENEROS BIOPHARMA LTD
    公开号:WO2020216378A1
    公开(公告)日:2020-10-29
    一种如式XI所示的含杂环的化合物、其药学上可接受的盐、其溶剂合物或其药学上可接受的盐的溶剂合物,及其应用及含其的组合物。该类化合物的结构新颖,具有较佳的STAT5抑制活性。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物